Ovid Therapeutics Inc.OVIDNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
-9.4%/yr
vs +14.1%/yr prior
5Y CAGR
-4.7%/yr
Recent deceleration
Acceleration
-23.5pp
Decelerating
Percentile
P55
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
4 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $24.11M | -6.1% |
| 2024 | $25.68M | -13.2% |
| 2023 | $29.59M | -8.8% |
| 2022 | $32.43M | -12.9% |
| 2021 | $37.23M | +21.6% |
| 2020 | $30.63M | +59.1% |
| 2019 | $19.25M | +0.6% |
| 2018 | $19.14M | +27.3% |
| 2017 | $15.04M | +16.1% |
| 2016 | $12.95M | - |